J Breast Cancer.  2015 Dec;18(4):409-410. 10.4048/jbc.2015.18.4.409.

Comment to "Vitamin D Receptor Poly(A) Microsatellite Polymorphism and 25-Hydroxyvitamin D Serum Levels: Association with Susceptibility to Breast Cancer"

• Chirumbolo S

• KMID: 2176296
• DOI: http://doi.org/10.4048/jbc.2015.18.4.409

Abstract

No abstract available.

MeSH Terms

Breast*
Microsatellite Repeats*

Reference

1. Colagar AH, Firouzjah HM, Halalkhor S. Vitamin D receptor poly(A) microsatellite polymorphism and 25-hydroxyvitamin D serum levels: association with susceptibility to breast cancer. J Breast Cancer. 2015; 18:119–125.

2. Thanasitthichai S, Chaiwerawattana A, Prasitthipayong A. Association of vitamin D level with clinicopathological features in breast cancer. Asian Pac J Cancer Prev. 2015; 16:4881–4883.

3. Martin-Herranz A, Salinas-Hernández P. Vitamin D supplementation review and recommendations for women diagnosed with breast or ovary cancer in the context of bone health and cancer prognosis/risk. Crit Rev Oncol Hematol. 2015; 96:91–99.

4. Chirumbolo S. Vitamin D3 in cancer prevention and therapy: the nutritional issue. Horm Mol Biol Clin Investig. 2015; 23:71–78.

5. Wang H, Wang W, Yang D, Wang S. TaqI polymorphism of VDR gene contributes to breast cancer risk. Tumour Biol. 2014; 35:93–102.

6. Han XM, Zhou HH. Polymorphism of CYP450 and cancer susceptibility. Acta Pharmacol Sin. 2000; 21:673–679.

7. Matsunawa M, Akagi D, Uno S, Endo-Umeda K, Yamada S, Ikeda K, et al. Vitamin D receptor activation enhances benzo[a]pyrene metabolism via CYP1A1 expression in macrophages. Drug Metab Dispos. 2012; 40:2059–2066.

8. Gupta RP, He YA, Patrick KS, Halpert JR, Bell NH. CYP3A4 is a vitamin D-24- and 25-hydroxylase: analysis of structure function by site-directed mutagenesis. J Clin Endocrinol Metab. 2005; 90:1210–1219.

9. Hauser K, Walsh D, Shrotriya S, Karafa M. Low 25-hydroxyvitamin D levels in people with a solid tumor cancer diagnosis: the tip of the iceberg? Support Care Cancer. 2014; 22:1931–1939.

10. Zeichner SB, Koru-Sengul T, Shah N, Liu Q, Markward NJ, Montero AJ, et al. Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer. Clin Breast Cancer. 2015; 15:e1–e11.

11. Chiang KC, Yen CL, Yeh CN, Hsu JT, Chen LW, Kuo SF, et al. Hepatocellular carcinoma cells express 25(OH)D-1α-hydroxylase and are able to convert 25(OH)D to 1α,25(OH)2D, leading to the 25(OH)D-induced growth inhibition. J Steroid Biochem Mol Biol. 2015; 154:47–52.

12. Yang X, Solomon S, Fraser LR, Trombino AF, Liu D, Sonenshein GE, et al. Constitutive regulation of CYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue. J Cell Biochem. 2008; 104:402–417.

13. Hefler LA, Tempfer CB, Grimm C, Lebrecht A, Ulbrich E, Heinze G, et al. Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women. Cancer. 2004; 101:264–269.

14. Cauchi S, Stücker I, Cénée S, Kremers P, Beaune P, Massaad-Massade L. Structure and polymorphisms of human aryl hydrocarbon receptor repressor (AhRR) gene in a French population: relationship with CYP1A1 inducibility and lung cancer. Pharmacogenetics. 2003; 13:339–347.

15. Blackburn HL, Ellsworth DL, Shriver CD, Ellsworth RE. Role of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism, and response to endocrine therapy. Cancer Causes Control. 2015; 26:319–332.

16. Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, Bhatnagar D, et al. Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians. Cancer Detect Prev. 2009; 32:386–394.

17. Zhang K, Song L. Association between vitamin D receptor gene polymorphisms and breast cancer risk: a meta-analysis of 39 studies. PLoS One. 2014; 9:e96125.

18. Gandini S, Gnagnarella P, Serrano D, Pasquali E, Raimondi S. Vitamin D receptor polymorphisms and cancer. Adv Exp Med Biol. 2014; 810:69–105.

19. Salimi S, Farajian-Mashhadi F, Alavi-Naini R, Talebian G, Narooie-Nejad M. Association between vitamin D receptor polymorphisms and haplotypes with pulmonary tuberculosis. Biomed Rep. 2015; 3:189–194.

20. Lombard Z, Dalton DL, Venter PA, Williams RC, Bornman L. Association of HLA-DR, -DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa. Hum Immunol. 2006; 67:643–654.

21. Mahmoodi M, Nahvi H, Mahmoudi M, Kasaian A, Mohagheghi MA, Divsalar K, et al. HLA-DRB1,-DQA1 and -DQB1 allele and haplotype frequencies in female patients with early onset breast cancer. Pathol Oncol Res. 2012; 18:49–55.